The global laboratory information systems market was is valued at $1.8bn in 2017 and is expected to grow at a CAGR of 8.3% from 2018 to 2028. In 2017, the software segment held 71% of the global laboratory information systems market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Laboratory Information Systems Market outlook from 2018-2028
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by delivery: • Web-based • On-Premise based • Cloud-based
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by application: • Clinical • Drug Discovery • Industrial
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by component: • Software • Hardware • Services
• This report provides individual revenue forecasts from 2018-2028 for these regional and national markets: • North America: US, Canada, Mexico • Europe: UK, Germany, France, Rest of Europe • Asia-Pacific: Japan, China, India, Rest of Asia-Pacific • Rest of the World (RoW)
• Our study discusses the selected leading companies that are the major players in the laboratory information systems market: • Abbott Laboratories • Cerner Corporation • Eclipsys Corporation • LabVantage Solutions, Inc. • LabWare, Inc. • McKesson Corporation • Medical Information Technology, Inc. • Thermo Fisher Scientific
• This report provides a Porter’s Five Forces Analysis of the global laboratory information systems market.
Visiongain’s study is intended for anyone requiring commercial analyses for the biologics market. You find data, trends and predictions.
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032
The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.
The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.
Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032
The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.
